Nagpur
+919405117673
+919405117673

Elromo 25 mg / 50 mg / 75 mg Tablets (Eltrombopag) – Global Supplier from India Trusted Exporter

Elromo Tablets (Eltrombopag 25 mg / 50 mg / 75 mg) are advanced thrombopoietin receptor agonists designed to increase platelet production in patients with serious blood disorders. Cordium Pharmaceuticals Pvt Ltd (India) provides authentic medicines with fast and reliable global delivery. 🚚 Fast Delivery Available In: Washington, New York (USA) | London (UK) | Canada | Abu Dhabi | Oman | Dubai (UAE) | Johannesburg | Cape Town (South Africa) Product Details Product Name: Elromo Tablets Generic Name: Eltrombopag Strengths: 25 mg / 50 mg / 75 mg Form: Oral Tablets Category: Hematology / Platelet Booster Uses of Elromo (Eltrombopag) Elromo is widely used for: Treatment of Chronic Immune Thrombocytopenia (ITP) Management of severe aplastic anemia Increasing platelet count in chronic liver disease patients Reducing risk of bleeding complications Dosage & Administration Taken orally once daily or as prescribed Dosage depends on: Platelet count Patient condition Response to treatment Should be taken on an empty stomach Avoid calcium-rich foods (milk, dairy) around dosing time ⚠️ Regular monitoring of platelet levels is essential. Side Effects Common side effects: Headache Nausea Fatigue Diarrhea Serious side effects: Liver dysfunction Blood clots (thrombosis) Cataracts (rare) Bone marrow abnormalities Precautions Monitor liver function and platelet count regularly Use cautiously in patients with liver disease Avoid overdose to reduce risk of clotting complications Inform doctor about all medications and supplements Use only under medical supervision Why Choose Cordium Pharmaceuticals Pvt Ltd? ✔ Leading Eltrombopag Tablet Supplier India ✔ Competitive global pricing ✔ Genuine and quality-assured pharmaceutical products ✔ Fast worldwide shipping ✔ Trusted exporter to USA, UK, UAE, Canada & South Africa Contact for Global Orders 📱 WhatsApp: +91-9405117673 📧 Email: info@cordiumpharma.com
 2026-04-01T07:33:42

Keywords